That disease has a great name. It's an awesome name.
You'll love to say this. Paroxysmal nocturnal hemoglobinuria or PNH.
It's called that because hemoglobinuria, what we're gonna end up doing is rupturing red cells.
And the hemoglobin that comes out of those ruptured red cells are gonna show up in the urine.
It turns out, in about 10% of patients, it happens mostly at night.
The reasons are not important.
So, we still call it nocturnal hemoglobinuria, and it only happens every now
and then, hence the name paroxysmal nocturnal hemoglobinuria.
Anyway, I just like saying it.
This is a disease that is a real disease,
real people get this that is related to loss of that GPI linkage.
So, on the X chromosome, there is an enzyme.
There is a gene that's called PIG-A.
And PIG-A makes the protein that's gonna be responsible for doing the enzymatic linkage
that makes that GPI linkage. If we lose that, if the enzyme becomes defective,
and it's an acquired mutation, you're not born this way,
at least not that we know of, but you acquire this as a mutation over time,
you lose the ability to make the GPI linkage.
Well, it turns out, there's some very important proteins
that are linked to cell membranes through GPI.
A couple of those are the decay-accelerating factor or DAF and CD55.
Those two molecules are important in inhibiting complement.
So, complement, as we'll talk about when we talk about inflammation,
and we talk about immune-mediated injury,
complement is a series of proteins synthesized
by the liver that punch holes in bacteria and fungus.
That's their job. But they're pretty non-discriminant,
and they will punch holes if activated appropriately in every other cell in the body.
So, every other cell in us makes these inhibitory proteins, DAF and CD55.
And that prevents unwanted complement from punching holes in you.
So, normally, because of the GPI-linked proteins, DAF and CD55, no problem.
If you have this disease with mutation in your PIG-A, now you can't inhibit complement.
And that complement is floating around,
getting activated periodically in the bloodstream,
and it will sit down now on a red cell, who can't defend itself.
That red cell then will have a bunch of holes punched in it, and out will ooze hemoglobin.
And so, now, we're gonna get hemoglobinuria.
It's actually causing -- rupture these red cells all over the place,
so the patients functioning end up with a severe anemia.
They will require transfusions.
They clearly get fatigued because there's not enough oxygen carrying capacity.
They are dyspneic, they are short of breath.
And in patients who have ongoing coronary artery disease, they may get angina.
So, this is not a trivial disease.
And it's a real consequence of understanding kind of the cell biology
in the way these proteins are linked.
It's also not just punching holes in red cells.
It's punching holes in white cells. In neutrophils, for example.
And so, patients with this disease will also get recurrent infections
cuz they can't protect themselves, cuz all of their white cells had been punched full of holes.
And that clone. So, it turns out that loss of that particular protein activity gives --
confers to the cell who's lost it, a growth advantage.
And in the bone marrow, those cells tend to expand.
So, there's expansion of a mutant clone lacking the PIG-A and enzymatic activity.
They grow better, and as they're growing better and faster,
they tend to acquire mutation, so there's an increased risk of leukemia.
So, an interesting disease. Fortunately, not that common.
This may be the only time you ever hear about it, but it's related to cell biology, and it's so cool.
And it's the concept that's most important anyway.
The coolness is just kind of the disease.